Merck Scraps Once-Promising Follow-On Biologic For Anemia

Published On: May 12th, 2010

The company has two other follow-on biologics in clinical development and expects at least five to be in the late stages of testing by 2012.

See the original post here:
Merck Scraps Once-Promising Follow-On Biologic For Anemia

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

Did you know:

African-American women have the highest death rates from heart disease, breast and lung cancer, stroke, and pregnancy among women of all racial and ethnic backgrounds

unhealthytruth : What do the world's most powerful pesticide executives eat for dinner? Insight from a dinner with the biotech industry http://t.co/eBkfBGYr

2012-05-23T14:21:37Z - Reply - View Tweet
elenadevanadera : Sa biotech pa ang Lab ng isang subjects ko! WTF

2012-05-23T14:21:37Z - Reply - View Tweet
LianNikole : @JHEillybeans21 Halaaaaaaaaa ! Mahirap po ba ? Kinakabahan ako sa math eh . tsaka sa chem. Pati biotech ! Kinakabahan ako sa lahat :{{ haha

2012-05-23T14:20:40Z - Reply - View Tweet
LathropTLH : The biggest R&D spenders in biotech - FierceBiotech: http://t.co/HfoMf4xC

2012-05-23T14:20:18Z - Reply - View Tweet
chilebiotech : Planning for EXPO BIOTECH (October 15-16) in northern #Chile is already underway. Banner here: http://t.co/KoA4TuIb #biotech via @latingene

2012-05-23T14:20:14Z - Reply - View Tweet
bcambridge_inv : RT @EBDgroup: Looking to strike a deal? Present at BIO-Europe� to big pharma & leading biotech investors. Apply by July 15. http://t.co/hFtJxzFB #BEU12

2012-05-23T14:18:35Z - Reply - View Tweet
bcambridge_inv : RT @EBDgroup: Mark your calendars for BioPharm America in Boston this Sept, the largest US biotech partnering & investor event #BPA12 http://t.co/MpNnIDSn

2012-05-23T14:18:20Z - Reply - View Tweet

Wrestling With the High Price of Biologic Drugs
Everyone agrees on the need for patient registries to collect more data on what works and what doesn’t — and for whom. ..
Hospital Blood Tests Tied to Anemia in Heart-Attack Patients
Ask anyone who’s spent time in the hospital — patients get a lot of blood taken over the course of their stay. A blood test can provide crucial information that can’t be gotten any other way. ..
Amgen and J&J Anemia Drugs Recalled on Concerns of Glass Flakes
Amgen is recalling certain lots of epoetin alfa, which it sells under the Epogen name and which Johnson & Johnson markets under the Procrit brand. ..
J&J Recall Watch: Eprex Anemia Drug Pulled on Potency Worries
Johnson & Johnson has recalled about 200,000 syringes of its Eprex anemia drug at the wholesale and pharmacy level because some batches of the drug may not be sufficiently potent. As the WSJ reports , the recall affects products in 17 countries, including the U.K. and Canada but not the U.S. ..
New Merck Management: A Lot Like the Old Merck Management
Merck just described what the company’s new management team will look like after the company’s merger with Schering-Plough goes through (assuming it’s cleared by regulators). The bottom line: Several key people in top positions at Merck will keep their jobs in the combined company. Dick Clark, Merck’s CEO, will run the combined show. ..
Merck Bracing for Health-Care Reform Challenges
Merck CEO Kenneth C. Frazier discusses the high cost of pharmaceuticals in the U.S. and challenges posted by President Obama’s health-care reform legislation with WSJ’s Alan Murray. ..

Orshe